In short. When the product is not standardised, the provider is the part you can assess. The questions that expose what is being injected, and by whom.
Key points
- A nodule, a firm lump, a delayed reaction at month four, after the course has ended and the payments are finished.
- Ask who to contact, how to reach them, and whether the practice will still have your record.
- A provider that has an answer to this has thought about the treatment rather than about the sale.
With a manufactured product, a patient can check the product and treat the provider as one part of the decision. With a mixture that is not standardised, the product cannot be checked by anyone outside the room, so the provider carries almost the whole weight. That is an uncomfortable thing to say and it is the practical truth of this subject.
Questions about the substance
Ask what is in the plan as a list of substances rather than a brand or a treatment name. Then ask which of those arrived as licensed products and which were prepared for the occasion, and what that means for how they were made and stored. Ask which ingredient carries the study record and which does not. These are factual questions, they have factual answers, and the way a clinic handles them is the clearest signal available about how the rest of the treatment will be conducted.
Questions about the plan
Ask how many sessions are planned, how far apart, and at what point the course will be judged rather than extended. Ask what the review looks like and what would make the answer no. A clinic working to a plan will have answers ready, because these are the questions it asks itself. A clinic working to a calendar will treat them as objections.
Ask what happens if something appears later
A nodule, a firm lump, a delayed reaction at month four, after the course has ended and the payments are finished. Ask who to contact, how to reach them, and whether the practice will still have your record. A provider that has an answer to this has thought about the treatment rather than about the sale.
Questions about accountability
Ask which clinician is accountable for the plan and whether that person has examined you. Ask what is written in your record at each visit and whether you can have a copy. In a treatment where the substance cannot be independently identified afterwards, the record is the only durable thing you leave with, and the practice that treats it as routine is the practice worth considering.
What no provider can tell you
No provider can tell you what a mixture will do, because for most mixtures nobody knows. What a good provider can do is list the substances, describe what is known about each, state the plan and the review point, and say plainly which parts are uncertain. That is a narrower offer than one built on confidence, and it is the honest one.
These are reasons to leave
- That the contents cannot be listed, only described as a formula or a blend.
- That the plan has no number of sessions and no review point.
- That questions about the record are treated as a lack of trust.
What an ingredient list is worth asking about is set out in What Is in the Injection?, and the approval questions behind it are in Approved for What?.
Frequently asked questions
What is the single most useful question to ask a clinic?
What is in the injection, written as a list of substances. It is answerable, it is checkable, and the way it is answered tells you most of what you need to know. A clinic that can produce the list and explain which parts are licensed is a clinic that has thought about the question before you asked it.
Should I choose a hospital rather than a clinic for this?
That is a decision about your own circumstances rather than a rule. What matters is whether the place can handle what it starts: whether there is a clinician accountable for the plan, a record you can take away, and somewhere to go if a nodule or a reaction appears after the course has ended. Ask how that last part works before you need it.
How do I judge a provider I have already used?
Ask for the record of what was injected, and see what comes back. If the substances, areas and dates are available, the practice is keeping the documentation this treatment depends on. If nothing can be produced, that is information about the practice rather than about your skin, and it is worth having before you decide whether to return.
Risks & Limitations
- Mesotherapy names a technique, not a product. The mixture is often prepared rather than manufactured, and it has not been assessed as a mixture.
- Any change reported is usually modest, lies in surface quality rather than in volume, and fades without further sessions.
- Firm lumps and delayed reactions can appear weeks to months after a session, and the date they appear is part of how they are assessed.
- A mixture is not standardised between clinics or between sessions, so the evidence for one plan says nothing about the next.
When to Seek Care
- Severe pain out of proportion to the procedure, or skin turning white, grey, mottled or dusky, needs immediate assessment.
- Any change in vision after an injection requires emergency care.
- Fever, or redness, warmth or discharge at a treated area that is spreading rather than settling.
- A firm lump or nodule appearing weeks or months later, which should be reported when noticed rather than at a review.
References & Further Reading
- American Society of Plastic Surgeons (ASPS) — procedure and safety guidance
- National Institute for Health and Care Excellence (NICE, UK) — relevant guidance
- Cochrane Library — systematic reviews
- Chinese Medical Association Plastic Surgery Branch — clinical guidance
This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.